Virtual Medicinal Product (VMP)
-
Dabrafenib 75mg capsules
Name Details
Current Name
Dabrafenib 75mg capsules
|
Start Date
04-09-2013
|
End Date
|
Unit Dose & Form Information
- DF Indicator
- Discrete
- UDFS Indicator
- 1.0
- UDFS UOM
- capsule
- Unit Dose UOM
- capsule
Summary
- Prescribing Status
- Valid as a prescribable product
- Controlled Drug Category
- No Controlled Drug Status
- Route
- Oral
- Form
- Oral capsule
- Ontology Form/Route
- capsule.oral
- Name Basis
- rINN - Recommended International Non-proprietary
Codes
- ATC Code
-
L01EC02
BNF |
Current BNF
08010500
|
Start Date
01-01-2025
|
End Date
|
Previous BNF
08020400
|
Start Date
04-04-2022
|
End Date
31-12-2024
|
Previous BNF
08010500
|
Start Date
25-06-2014
|
End Date
03-04-2022
|
SNOMED Codes
Code
|
Start Date
|
End Date
|
41761011000001106 |
09-05-2023 |
|
703648007 |
01-10-2014 |
08-05-2023 |
23107611000001107 |
04-09-2013 |
30-09-2014 |
VMP Ingredients
Name
Dabrafenib mesilate
Basis of strength description
Based on Base Substance
BOSS
Dabrafenib
Strength and UOM (Nmr)
75.0
Strength and UOM (Dmr)
Parent Products
-
VTM
Dabrafenib
-
VMP
(Current) Dabrafenib 75mg capsules
Virtual Medicinal Product Pack (VMPP) Information